ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II (2022)
Malmegrim, Kelen Cristina Ribeiro ; Toubert, A.; Farge, D.; Rodrigues, Maria Carolina de Oliveira
Fonte: Frontiers in Immunology. Unidades: FCFRP, FMRP
Assuntos: DOENÇAS AUTOIMUNES, TRANSPLANTE AUTÓLOGO, CÉLULAS-TRONCO, ESCLEROSE MÚLTIPLA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALMEGRIM, Kelen Cristina Ribeiro et al. Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II. Frontiers in Immunology. Lausanne: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fimmu.2022.1038338. Acesso em: 04 jul. 2024. , 2022
APA
Malmegrim, K. C. R., Toubert, A., Farge, D., & Rodrigues, M. C. de O. (2022). Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II. Frontiers in Immunology. Lausanne: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.3389/fimmu.2022.1038338
NLM
Malmegrim KCR, Toubert A, Farge D, Rodrigues MC de O. Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II [Internet]. Frontiers in Immunology. 2022 ; 13 1-3.[citado 2024 jul. 04 ] Available from: https://doi.org/10.3389/fimmu.2022.1038338
Vancouver
Malmegrim KCR, Toubert A, Farge D, Rodrigues MC de O. Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II [Internet]. Frontiers in Immunology. 2022 ; 13 1-3.[citado 2024 jul. 04 ] Available from: https://doi.org/10.3389/fimmu.2022.1038338
Artigo de periodico
Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy (2022)
Gonçalves, Maynara Santana; Silva, Djúlio César Zanin da; Henrique Neto, Álvaro; Moraes, Daniela Aparecida de; Vasconcelos, Marianna Yumi Kawashima; Lima Júnior, João Rodrigues; Dias, Juliana Bernardes Elias; Bragagnollo, Vinícius; Azevedo, Júlia Teixeira Cottas de; Covas, Dimas Tadeu; Farias, Kelen Cristina Ribeiro Malmegrim de ; Ramalho, Leandra Naira Zambelli ; Rodrigues, Maria Carolina de Oliveira
Fonte: Therapeutic Advances in Musculoskeletal Disease. Unidades: FMRP, FCFRP
Assuntos: BIOMARCADORES, CÉLULAS, ENDOTÉLIO, DOENÇA CRÔNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONÇALVES, Maynara Santana et al. Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy. Therapeutic Advances in Musculoskeletal Disease, v. 14, p. 1- 13, 2022Tradução . . Disponível em: https://doi.org/10.1177/1759720X221084845. Acesso em: 04 jul. 2024.
APA
Gonçalves, M. S., Silva, D. C. Z. da, Henrique Neto, Á., Moraes, D. A. de, Vasconcelos, M. Y. K., Lima Júnior, J. R., et al. (2022). Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy. Therapeutic Advances in Musculoskeletal Disease, 14, 1- 13. doi:10.1177/1759720X221084845
NLM
Gonçalves MS, Silva DCZ da, Henrique Neto Á, Moraes DA de, Vasconcelos MYK, Lima Júnior JR, Dias JBE, Bragagnollo V, Azevedo JTC de, Covas DT, Farias KCRM de, Ramalho LNZ, Rodrigues MC de O. Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy [Internet]. Therapeutic Advances in Musculoskeletal Disease. 2022 ; 14 1- 13.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1177/1759720X221084845
Vancouver
Gonçalves MS, Silva DCZ da, Henrique Neto Á, Moraes DA de, Vasconcelos MYK, Lima Júnior JR, Dias JBE, Bragagnollo V, Azevedo JTC de, Covas DT, Farias KCRM de, Ramalho LNZ, Rodrigues MC de O. Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy [Internet]. Therapeutic Advances in Musculoskeletal Disease. 2022 ; 14 1- 13.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1177/1759720X221084845
Artigo de periodico
Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients (2022)
Silva, Djúlio César Zanin da; Gonçalves, Maynara Santana; Vasconcelos, Marianna Yumi Kawashima; Lima Júnior, João Rodrigues; Dias, Juliana Bernardes Elias; Moraes, Daniela A.; Covas, Dimas Tadeu; Farias, Kelen Cristina Ribeiro Malmegrim de ; Ramalho, Leandra Naíra Zambelli; Rodrigues, Maria Carolina de Oliveira
Fonte: Arthritis Research & Therapy. Unidades: FMRP, FCFRP
Assuntos: TECIDO CONJUNTIVO, DOENÇA CRÔNICA, DOENÇAS AUTOIMUNES, FIBROBLASTOS, CÉLULAS-TRONCO, MATRIZ EXTRACELULAR, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Djúlio César Zanin da et al. Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients. Arthritis Research & Therapy, v. 24, n. 1, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1186/s13075-022-02779-w. Acesso em: 04 jul. 2024.
APA
Silva, D. C. Z. da, Gonçalves, M. S., Vasconcelos, M. Y. K., Lima Júnior, J. R., Dias, J. B. E., Moraes, D. A., et al. (2022). Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients. Arthritis Research & Therapy, 24( 1), 1-11. doi:10.1186/s13075-022-02779-w
NLM
Silva DCZ da, Gonçalves MS, Vasconcelos MYK, Lima Júnior JR, Dias JBE, Moraes DA, Covas DT, Farias KCRM de, Ramalho LNZ, Rodrigues MC de O. Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients [Internet]. Arthritis Research & Therapy. 2022 ; 24( 1): 1-11.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1186/s13075-022-02779-w
Vancouver
Silva DCZ da, Gonçalves MS, Vasconcelos MYK, Lima Júnior JR, Dias JBE, Moraes DA, Covas DT, Farias KCRM de, Ramalho LNZ, Rodrigues MC de O. Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients [Internet]. Arthritis Research & Therapy. 2022 ; 24( 1): 1-11.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1186/s13075-022-02779-w
Artigo de periodico
Reconstitution of the immune system and clinical correlates after stem cell transplantation for systemic sclerosis (2022)
Vasconcelos, Marianna Yumi Kawashima; Gonçalves, Maynara Santana; Silva, Djúlio César Zanin da; Farias, Kelen Cristina Ribeiro Malmegrim de ; Rodrigues, Maria Carolina de Oliveira
Fonte: Frontiers in Immunology. Unidades: FCFRP, FMRP
Assuntos: AUTOIMUNIDADE, SISTEMA IMUNE, TRANSPLANTE AUTÓLOGO, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VASCONCELOS, Marianna Yumi Kawashima et al. Reconstitution of the immune system and clinical correlates after stem cell transplantation for systemic sclerosis. Frontiers in Immunology, v. 13, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.941011. Acesso em: 04 jul. 2024.
APA
Vasconcelos, M. Y. K., Gonçalves, M. S., Silva, D. C. Z. da, Farias, K. C. R. M. de, & Rodrigues, M. C. de O. (2022). Reconstitution of the immune system and clinical correlates after stem cell transplantation for systemic sclerosis. Frontiers in Immunology, 13, 1-16. doi:10.3389/fimmu.2022.941011
NLM
Vasconcelos MYK, Gonçalves MS, Silva DCZ da, Farias KCRM de, Rodrigues MC de O. Reconstitution of the immune system and clinical correlates after stem cell transplantation for systemic sclerosis [Internet]. Frontiers in Immunology. 2022 ; 13 1-16.[citado 2024 jul. 04 ] Available from: https://doi.org/10.3389/fimmu.2022.941011
Vancouver
Vasconcelos MYK, Gonçalves MS, Silva DCZ da, Farias KCRM de, Rodrigues MC de O. Reconstitution of the immune system and clinical correlates after stem cell transplantation for systemic sclerosis [Internet]. Frontiers in Immunology. 2022 ; 13 1-16.[citado 2024 jul. 04 ] Available from: https://doi.org/10.3389/fimmu.2022.941011
Artigo de periodico
Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients (2022)
Jarduli, Luciana Ribeiro; Azevedo, Júlia Teixeira Cottas de; Clave, Emmanuel; Costa, Thalita Cristina de Mello; Arruda, Lucas Coelho Marliére; Fournier, Isabelle; Palma, Patricia Vianna Bonini; Lima, Keli Cristina de; Dias, Juliana Bernardes Elias; Stracieri, Ana Beatriz Pereira Lima; Pieroni, Fabiano; Cunha, Renato Luiz Guerino; Darrigo Júnior, Luiz Guilherme; Grecco, Carlos Eduardo Setanni; Covas, Dimas Tadeu; Pinto, Ana Cristina Silva; De Santis, Gil Cunha; Simões, Belinda Pinto; Rodrigues, Maria Carolina de Oliveira; Toubert, Antoine; Farias, Kelen Cristina Ribeiro Malmegrim de
Fonte: Clinical & Translational Immunology. Unidades: FMRP, FCFRP, FM
Assuntos: CÉLULAS-TRONCO, HOMEOSTASE, REGENERAÇÃO (FENÔMENOS BIOLÓGICOS), ANEMIA FALCIFORME
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JARDULI, Luciana Ribeiro et al. Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients. Clinical & Translational Immunology, v. 11, n. 4, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.1002/cti2.1389. Acesso em: 04 jul. 2024.
APA
Jarduli, L. R., Azevedo, J. T. C. de, Clave, E., Costa, T. C. de M., Arruda, L. C. M., Fournier, I., et al. (2022). Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients. Clinical & Translational Immunology, 11( 4), 1-16. doi:10.1002/cti2.1389
NLM
Jarduli LR, Azevedo JTC de, Clave E, Costa TC de M, Arruda LCM, Fournier I, Palma PVB, Lima KC de, Dias JBE, Stracieri ABPL, Pieroni F, Cunha RLG, Darrigo Júnior LG, Grecco CES, Covas DT, Pinto ACS, De Santis GC, Simões BP, Rodrigues MC de O, Toubert A, Farias KCRM de. Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients [Internet]. Clinical & Translational Immunology. 2022 ; 11( 4): 1-16.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1002/cti2.1389
Vancouver
Jarduli LR, Azevedo JTC de, Clave E, Costa TC de M, Arruda LCM, Fournier I, Palma PVB, Lima KC de, Dias JBE, Stracieri ABPL, Pieroni F, Cunha RLG, Darrigo Júnior LG, Grecco CES, Covas DT, Pinto ACS, De Santis GC, Simões BP, Rodrigues MC de O, Toubert A, Farias KCRM de. Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients [Internet]. Clinical & Translational Immunology. 2022 ; 11( 4): 1-16.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1002/cti2.1389
Artigo de periodico
Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients (2021)
Lima-Júnior, João R.; Arruda, Lucas C. M.; Gonçalves, Maynara Santana; Dias, Juliana B. E.; Moraes, Daniela A.; Covas, Dimas Tadeu; Simões, Belinda Pinto; Oliveira, Maria Carolina; Malmegrim, Kelen Cristina Ribeiro
Fonte: Rheumatology. Unidades: FMRP, FCFRP
Assuntos: DOENÇAS AUTOIMUNES, TRANSPLANTE AUTÓLOGO, CÉLULAS-TRONCO, TRANSPLANTE DE ÓRGÃOS, INTERLEUCINAS, SISTEMA IMUNE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA-JÚNIOR, João R. et al. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients. Rheumatology, v. 60, n. 12, p. 5538–5548, 2021Tradução . . Disponível em: https://doi.org/10.1093/rheumatology/keab257. Acesso em: 04 jul. 2024.
APA
Lima-Júnior, J. R., Arruda, L. C. M., Gonçalves, M. S., Dias, J. B. E., Moraes, D. A., Covas, D. T., et al. (2021). Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients. Rheumatology, 60( 12), 5538–5548. doi:10.1093/rheumatology/keab257
NLM
Lima-Júnior JR, Arruda LCM, Gonçalves MS, Dias JBE, Moraes DA, Covas DT, Simões BP, Oliveira MC, Malmegrim KCR. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients [Internet]. Rheumatology. 2021 ; 60( 12): 5538–5548.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1093/rheumatology/keab257
Vancouver
Lima-Júnior JR, Arruda LCM, Gonçalves MS, Dias JBE, Moraes DA, Covas DT, Simões BP, Oliveira MC, Malmegrim KCR. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients [Internet]. Rheumatology. 2021 ; 60( 12): 5538–5548.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1093/rheumatology/keab257
Artigo de periodico
Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms (2021)
Cominal, Juçara Gastaldi; Cacemiro, Maira da Costa ; Berzoti-Coelho, Maria Gabriela ; Pereira, Illy Enne Gomes ; Frantz, Fabiani Gai ; Souto, Elizabeth Xisto; Covas, Dimas Tadeu; Figueiredo-Pontes, Lorena Lobo de; Oliveira, Maria Carolina; Malmegrim, Kelen Cristina Ribeiro ; Castro, Fabíola Attié de
Fonte: Frontiers in Oncology. Unidades: FCFRP, FMRP
Assuntos: NEOVASCULARIZAÇÃO PATOLÓGICA, MEDULA ÓSSEA, CITOCINAS, INFLAMAÇÃO, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COMINAL, Juçara Gastaldi et al. Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Frontiers in Oncology, v. 11, p. 1-12 , 2021Tradução . . Disponível em: https://doi.org/10.3389/fonc.2021.665037. Acesso em: 04 jul. 2024.
APA
Cominal, J. G., Cacemiro, M. da C., Berzoti-Coelho, M. G., Pereira, I. E. G., Frantz, F. G., Souto, E. X., et al. (2021). Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Frontiers in Oncology, 11, 1-12 . doi:10.3389/fonc.2021.665037
NLM
Cominal JG, Cacemiro M da C, Berzoti-Coelho MG, Pereira IEG, Frantz FG, Souto EX, Covas DT, Figueiredo-Pontes LL de, Oliveira MC, Malmegrim KCR, Castro FA de. Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms [Internet]. Frontiers in Oncology. 2021 ; 11 1-12 .[citado 2024 jul. 04 ] Available from: https://doi.org/10.3389/fonc.2021.665037
Vancouver
Cominal JG, Cacemiro M da C, Berzoti-Coelho MG, Pereira IEG, Frantz FG, Souto EX, Covas DT, Figueiredo-Pontes LL de, Oliveira MC, Malmegrim KCR, Castro FA de. Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms [Internet]. Frontiers in Oncology. 2021 ; 11 1-12 .[citado 2024 jul. 04 ] Available from: https://doi.org/10.3389/fonc.2021.665037
Artigo de periodico
Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor (2021)
Noronha, Nadia de Cássia; Mizukami, Amanda; Orellana, Maristela Delgado; Oliveira, Maria Carolina de; Covas, Dimas Tadeu; Swiech, Kamilla; Malmegrim, Kelen Cristina Ribeiro
Fonte: Biochemical Engineering Journal. Unidades: FMRP, FCFRP
Assuntos: CÉLULAS ESTROMAIS, ANÓXIA, REATORES BIOQUÍMICOS, ADJUVANTES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NORONHA, Nadia de Cássia et al. Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor. Biochemical Engineering Journal, v. 168, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bej.2021.107949. Acesso em: 04 jul. 2024.
APA
Noronha, N. de C., Mizukami, A., Orellana, M. D., Oliveira, M. C. de, Covas, D. T., Swiech, K., & Malmegrim, K. C. R. (2021). Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor. Biochemical Engineering Journal, 168, 1-11. doi:10.1016/j.bej.2021.107949
NLM
Noronha N de C, Mizukami A, Orellana MD, Oliveira MC de, Covas DT, Swiech K, Malmegrim KCR. Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor [Internet]. Biochemical Engineering Journal. 2021 ; 168 1-11.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1016/j.bej.2021.107949
Vancouver
Noronha N de C, Mizukami A, Orellana MD, Oliveira MC de, Covas DT, Swiech K, Malmegrim KCR. Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor [Internet]. Biochemical Engineering Journal. 2021 ; 168 1-11.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1016/j.bej.2021.107949
Artigo de periodico-carta/editorial
Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand? (2020)
Farias, Kelen Cristina Ribeiro Malmegrim de ; Toubert, Antoine; Farge, Dominique; Rodrigues, Maria Carolina de Oliveira
Fonte: Frontiers in Immunology. Unidades: FCFRP, FMRP
Assuntos: TRANSPLANTES, CÉLULAS-TRONCO, DOENÇAS AUTOIMUNES, EDITORIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FARIAS, Kelen Cristina Ribeiro Malmegrim de et al. Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand?. Frontiers in Immunology. Lausanne: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fimmu.2019.03044. Acesso em: 04 jul. 2024. , 2020
APA
Farias, K. C. R. M. de, Toubert, A., Farge, D., & Rodrigues, M. C. de O. (2020). Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand? Frontiers in Immunology. Lausanne: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.3389/fimmu.2019.03044
NLM
Farias KCRM de, Toubert A, Farge D, Rodrigues MC de O. Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand? [Internet]. Frontiers in Immunology. 2020 ; 10[citado 2024 jul. 04 ] Available from: https://doi.org/10.3389/fimmu.2019.03044
Vancouver
Farias KCRM de, Toubert A, Farge D, Rodrigues MC de O. Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand? [Internet]. Frontiers in Immunology. 2020 ; 10[citado 2024 jul. 04 ] Available from: https://doi.org/10.3389/fimmu.2019.03044
Parte de monografia/livro
New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement (2020)
Couri, Carlos Eduardo Barra; Farias, Kelen Cristina Ribeiro Malmegrim de ; Rodrigues, Maria Carolina de Oliveira
Fonte: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. Unidades: FCFRP, FMRP
Assuntos: AUTOIMUNIDADE, CÉLULAS VEGETAIS, TRANSPLANTE DE ÓRGÃOS, BIOMARCADORES, DIABETES MELLITUS, TRANSPLANTE AUTÓLOGO, IMUNOSSUPRESSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COURI, Carlos Eduardo Barra e FARIAS, Kelen Cristina Ribeiro Malmegrim de e RODRIGUES, Maria Carolina de Oliveira. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement. Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Tradução . Lausanne: Frontiers Media, 2020. . Disponível em: https://doi.org/10.3389/978-2-88963-472-9. Acesso em: 04 jul. 2024.
APA
Couri, C. E. B., Farias, K. C. R. M. de, & Rodrigues, M. C. de O. (2020). New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement. In Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. Lausanne: Frontiers Media. doi:10.3389/978-2-88963-472-9
NLM
Couri CEB, Farias KCRM de, Rodrigues MC de O. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2024 jul. 04 ] Available from: https://doi.org/10.3389/978-2-88963-472-9
Vancouver
Couri CEB, Farias KCRM de, Rodrigues MC de O. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2024 jul. 04 ] Available from: https://doi.org/10.3389/978-2-88963-472-9
Artigo de periodico-carta/editorial
CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta] (2020)
Arruda, Lucas Coelho Marliére; Clave, Emmanuel; Douay, Corinne; Lima Júnior, João Rodrigues; Slavov, Svetoslav Nanev; Farias, Kelen Cristina Ribeiro Malmegrim de ; Alberdi, Antônio José; Rodrigues, Maria Carolina de Oliveira; Toubert, Antoine
Fonte: Rheumatology. Unidades: FMRP, FCFRP
Assuntos: CÉLULAS CLONAIS, IMUNOLOGIA, CITOMEGALOVIRUS, TRANSPLANTES, CÉLULAS-TRONCO, RECEPTORES, ANTÍGENOS, VIROLOGIA, TRANSPLANTE AUTÓLOGO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARRUDA, Lucas Coelho Marliére et al. CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta]. Rheumatology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/rheumatology/keaa001. Acesso em: 04 jul. 2024. , 2020
APA
Arruda, L. C. M., Clave, E., Douay, C., Lima Júnior, J. R., Slavov, S. N., Farias, K. C. R. M. de, et al. (2020). CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta]. Rheumatology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/rheumatology/keaa001
NLM
Arruda LCM, Clave E, Douay C, Lima Júnior JR, Slavov SN, Farias KCRM de, Alberdi AJ, Rodrigues MC de O, Toubert A. CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta] [Internet]. Rheumatology. 2020 ; 59( 9): e38-e40.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1093/rheumatology/keaa001
Vancouver
Arruda LCM, Clave E, Douay C, Lima Júnior JR, Slavov SN, Farias KCRM de, Alberdi AJ, Rodrigues MC de O, Toubert A. CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta] [Internet]. Rheumatology. 2020 ; 59( 9): e38-e40.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1093/rheumatology/keaa001
Parte de monografia/livro
Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? (2020)
Farias, Kelen Cristina Ribeiro Malmegrim de ; Toubert, Antoine; Farge, Dominique; Rodrigues, Maria Carolina de Oliveira
Fonte: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. Unidades: FCFRP, FMRP
Assuntos: TRANSPLANTES, CÉLULAS-TRONCO, DOENÇAS AUTOIMUNES, EDITORIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FARIAS, Kelen Cristina Ribeiro Malmegrim de et al. Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Tradução . Lausanne: Frontiers Media, 2020. . Disponível em: https://doi.org/10.3389/978-2-88963-472-9. Acesso em: 04 jul. 2024.
APA
Farias, K. C. R. M. de, Toubert, A., Farge, D., & Rodrigues, M. C. de O. (2020). Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? In Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. Lausanne: Frontiers Media. doi:10.3389/978-2-88963-472-9
NLM
Farias KCRM de, Toubert A, Farge D, Rodrigues MC de O. Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2024 jul. 04 ] Available from: https://doi.org/10.3389/978-2-88963-472-9
Vancouver
Farias KCRM de, Toubert A, Farge D, Rodrigues MC de O. Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2024 jul. 04 ] Available from: https://doi.org/10.3389/978-2-88963-472-9
Monografia/livro-ed/org
Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? (2020)
Farias, Kelen Cristina Ribeiro Malmegrim de (Editor) ; Rodrigues, Maria Carolina de Oliveira (Editor); Toubert, Antoine (Editor); Bancel, Dominique Farge (Editor)
Unidades: FCFRP, FMRP
Assuntos: TRANSPLANTES, CÉLULAS-TRONCO, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. . Lausanne: Frontiers Media. Disponível em: https://doi.org/10.3389/978-2-88963-472-9. Acesso em: 04 jul. 2024. , 2020
APA
Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? (2020). Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media. doi:10.3389/978-2-88963-472-9
NLM
Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? [Internet]. 2020 ;[citado 2024 jul. 04 ] Available from: https://doi.org/10.3389/978-2-88963-472-9
Vancouver
Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? [Internet]. 2020 ;[citado 2024 jul. 04 ] Available from: https://doi.org/10.3389/978-2-88963-472-9
Parte de monografia/livro
Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers (2020)
Farias, Kelen Cristina Ribeiro Malmegrim de ; Lima Júnior, João Rodrigues; Arruda, Lucas Coelho Marliére; Azevedo, Júlia Teixeira Cottas de; Oliveira, Gislane Lelis Vilela de; Rodrigues, Maria Carolina de Oliveira
Fonte: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. Unidades: FCFRP, FMRP
Assuntos: CÉLULAS-TRONCO, TRANSPLANTE DE ÓRGÃOS, DOENÇAS AUTOIMUNES, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FARIAS, Kelen Cristina Ribeiro Malmegrim de et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers. Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Tradução . Lausanne: Frontiers Media, 2020. . Disponível em: https://doi.org/10.3389/978-2-88963-472-9. Acesso em: 04 jul. 2024.
APA
Farias, K. C. R. M. de, Lima Júnior, J. R., Arruda, L. C. M., Azevedo, J. T. C. de, Oliveira, G. L. V. de, & Rodrigues, M. C. de O. (2020). Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers. In Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. Lausanne: Frontiers Media. doi:10.3389/978-2-88963-472-9
NLM
Farias KCRM de, Lima Júnior JR, Arruda LCM, Azevedo JTC de, Oliveira GLV de, Rodrigues MC de O. Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2024 jul. 04 ] Available from: https://doi.org/10.3389/978-2-88963-472-9
Vancouver
Farias KCRM de, Lima Júnior JR, Arruda LCM, Azevedo JTC de, Oliveira GLV de, Rodrigues MC de O. Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2024 jul. 04 ] Available from: https://doi.org/10.3389/978-2-88963-472-9
Artigo de periodico
Lower Insulin-Dose Adjusted A1c (IDAA1c) is associated with less complications in individuals with type 1 diabetes treated with hematopoetic stem-cell transplantation and conventional therapy (2019)
Saboia, Jaquellyne Gurgel Penaforte; Couri, Carlos Eduardo Barra; Fernandes, Virginia Oliveira; Montenegro, Ana Paula Dias Rangel; Batista, Lívia Aline de Araújo; Zajdenverg, Lenita; Negrato, Carlos Antonio ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Moraes, Daniela Aparecida de; Dias, Juliana Bernardes Elias; Oliveira, Maria Carolina ; Hussain, Akhtar; Gomes, Marilia Brito ; Montenegro Junior, Renan Magalhães
Fonte: Frontiers in Endocrinology. Unidades: FCFRP, FMRP
Assuntos: INSULINA, DIABETES MELLITUS, TRANSPLANTES, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABOIA, Jaquellyne Gurgel Penaforte et al. Lower Insulin-Dose Adjusted A1c (IDAA1c) is associated with less complications in individuals with type 1 diabetes treated with hematopoetic stem-cell transplantation and conventional therapy. Frontiers in Endocrinology, v. 10, p. [7] , 2019Tradução . . Disponível em: https://doi.org/10.3389/fendo.2019.00747. Acesso em: 04 jul. 2024.
APA
Saboia, J. G. P., Couri, C. E. B., Fernandes, V. O., Montenegro, A. P. D. R., Batista, L. A. de A., Zajdenverg, L., et al. (2019). Lower Insulin-Dose Adjusted A1c (IDAA1c) is associated with less complications in individuals with type 1 diabetes treated with hematopoetic stem-cell transplantation and conventional therapy. Frontiers in Endocrinology, 10, [7] . doi:10.3389/fendo.2019.00747
NLM
Saboia JGP, Couri CEB, Fernandes VO, Montenegro APDR, Batista LA de A, Zajdenverg L, Negrato CA, Farias KCRM de, Moraes DA de, Dias JBE, Oliveira MC, Hussain A, Gomes MB, Montenegro Junior RM. Lower Insulin-Dose Adjusted A1c (IDAA1c) is associated with less complications in individuals with type 1 diabetes treated with hematopoetic stem-cell transplantation and conventional therapy [Internet]. Frontiers in Endocrinology. 2019 ; 10 [7] .[citado 2024 jul. 04 ] Available from: https://doi.org/10.3389/fendo.2019.00747
Vancouver
Saboia JGP, Couri CEB, Fernandes VO, Montenegro APDR, Batista LA de A, Zajdenverg L, Negrato CA, Farias KCRM de, Moraes DA de, Dias JBE, Oliveira MC, Hussain A, Gomes MB, Montenegro Junior RM. Lower Insulin-Dose Adjusted A1c (IDAA1c) is associated with less complications in individuals with type 1 diabetes treated with hematopoetic stem-cell transplantation and conventional therapy [Internet]. Frontiers in Endocrinology. 2019 ; 10 [7] .[citado 2024 jul. 04 ] Available from: https://doi.org/10.3389/fendo.2019.00747
Trabalho de evento-resumo periodico
Differential reconstitution of B-cell subsets in systemic sclerosis patients after autologous hematopoietic stem cell transplantation (2019)
Lima Júnior, João Rodrigues; Arruda, Lucas Coelho Marliére; Gonçalves, Maynara Santana; Azevedo, Júlia Teixeira Cottas de; Moraes, Daniela A.; Covas, Dimas Tadeu ; Oliveira, Maria Carolina ; Farias, Kelen Cristina Ribeiro Malmegrim de
Fonte: Annals of the Rheumatic Diseases. Nome do evento: Annual European Congress of Rheumatology - EULAR. Unidades: FMRP, FCFRP
Assuntos: CÉLULAS-TRONCO, TRANSPLANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA JÚNIOR, João Rodrigues et al. Differential reconstitution of B-cell subsets in systemic sclerosis patients after autologous hematopoietic stem cell transplantation. Annals of the Rheumatic Diseases. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1136/annrheumdis-2019-eular.2863. Acesso em: 04 jul. 2024. , 2019
APA
Lima Júnior, J. R., Arruda, L. C. M., Gonçalves, M. S., Azevedo, J. T. C. de, Moraes, D. A., Covas, D. T., et al. (2019). Differential reconstitution of B-cell subsets in systemic sclerosis patients after autologous hematopoietic stem cell transplantation. Annals of the Rheumatic Diseases. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1136/annrheumdis-2019-eular.2863
NLM
Lima Júnior JR, Arruda LCM, Gonçalves MS, Azevedo JTC de, Moraes DA, Covas DT, Oliveira MC, Farias KCRM de. Differential reconstitution of B-cell subsets in systemic sclerosis patients after autologous hematopoietic stem cell transplantation [Internet]. Annals of the Rheumatic Diseases. 2019 ; 78 1065.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1136/annrheumdis-2019-eular.2863
Vancouver
Lima Júnior JR, Arruda LCM, Gonçalves MS, Azevedo JTC de, Moraes DA, Covas DT, Oliveira MC, Farias KCRM de. Differential reconstitution of B-cell subsets in systemic sclerosis patients after autologous hematopoietic stem cell transplantation [Internet]. Annals of the Rheumatic Diseases. 2019 ; 78 1065.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1136/annrheumdis-2019-eular.2863
Artigo de periodico-carta/editorial
Teplizumab in relatives at risk for type 1 diabetes. [Carta] (2019)
Couri, Carlos Eduardo Barra; Farias, Kelen Cristina Ribeiro Malmegrim de ; Oliveira, Maria Carolina
Fonte: New England Journal of Medicine. Unidades: FCFRP, FMRP
Assuntos: DIABETES MELLITUS, ANTICORPOS, LINFÓCITOS T, INSULINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COURI, Carlos Eduardo Barra e FARIAS, Kelen Cristina Ribeiro Malmegrim de e OLIVEIRA, Maria Carolina. Teplizumab in relatives at risk for type 1 diabetes. [Carta]. New England Journal of Medicine. Waltham: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1056/NEJMc1912500. Acesso em: 04 jul. 2024. , 2019
APA
Couri, C. E. B., Farias, K. C. R. M. de, & Oliveira, M. C. (2019). Teplizumab in relatives at risk for type 1 diabetes. [Carta]. New England Journal of Medicine. Waltham: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1056/NEJMc1912500
NLM
Couri CEB, Farias KCRM de, Oliveira MC. Teplizumab in relatives at risk for type 1 diabetes. [Carta] [Internet]. New England Journal of Medicine. 2019 ; 381( 19): 1879-1881.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1056/NEJMc1912500
Vancouver
Couri CEB, Farias KCRM de, Oliveira MC. Teplizumab in relatives at risk for type 1 diabetes. [Carta] [Internet]. New England Journal of Medicine. 2019 ; 381( 19): 1879-1881.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1056/NEJMc1912500
Artigo de periodico
Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis (2018)
Arruda, Lucas C. M. ; Lima-Júnior, João R.; Clave, Emmanuel; Moraes, Daniela A.; Douay, Corinne; Fournier, Isabelle; Moins-Teisserenc, Hélène; Covas, Dimas Tadeu ; Simões, Belinda Pinto ; Farge, Dominique; Toubert, Antoine; Farias, Kelen Cristina Ribeiro Malmegrim de ; Oliveira, Maria Carolina
Fonte: Bone Marrow Transplantation. Unidades: FMRP, FCFRP
Assuntos: TRANSPLANTE AUTÓLOGO, CÉLULAS-TRONCO, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARRUDA, Lucas C. M. et al. Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis. Bone Marrow Transplantation, v. 53, n. 10, p. 1319-1327, 2018Tradução . . Disponível em: https://doi.org/10.1038/s41409-018-0162-0. Acesso em: 04 jul. 2024.
APA
Arruda, L. C. M., Lima-Júnior, J. R., Clave, E., Moraes, D. A., Douay, C., Fournier, I., et al. (2018). Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis. Bone Marrow Transplantation, 53( 10), 1319-1327. doi:10.1038/s41409-018-0162-0
NLM
Arruda LCM, Lima-Júnior JR, Clave E, Moraes DA, Douay C, Fournier I, Moins-Teisserenc H, Covas DT, Simões BP, Farge D, Toubert A, Farias KCRM de, Oliveira MC. Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis [Internet]. Bone Marrow Transplantation. 2018 ; 53( 10): 1319-1327.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1038/s41409-018-0162-0
Vancouver
Arruda LCM, Lima-Júnior JR, Clave E, Moraes DA, Douay C, Fournier I, Moins-Teisserenc H, Covas DT, Simões BP, Farge D, Toubert A, Farias KCRM de, Oliveira MC. Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis [Internet]. Bone Marrow Transplantation. 2018 ; 53( 10): 1319-1327.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1038/s41409-018-0162-0
Artigo de periodico
Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients (2018)
Arruda, Lucas C. M. ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Lima Júnior, João Rodrigues; Clave, Emmanuel; Dias, Juliana Bernardes Elias; Moraes, Daniela A.; Douay, Corinne; Fournier, Isabelle; Moins-Teisserenc, Hélène; Alberdi, Antônio José; Covas, Dimas Tadeu ; Simões, Belinda Pinto ; Lansiaux, Pauline; Oliveira, Maria Carolina
Fonte: Blood Advances. Unidades: FMRP, FCFRP
Assuntos: TRANSPLANTES, CÉLULAS-TRONCO, SISTEMA IMUNE, LINFÓCITOS T, TRANSPLANTE AUTÓLOGO, TIMO (GLÂNDULA ENDÓCRINA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARRUDA, Lucas C. M. et al. Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients. Blood Advances, v. 2, n. 2, p. 126-141, 2018Tradução . . Disponível em: https://doi.org/10.1182/bloodadvances.2017011072. Acesso em: 04 jul. 2024.
APA
Arruda, L. C. M., Farias, K. C. R. M. de, Lima Júnior, J. R., Clave, E., Dias, J. B. E., Moraes, D. A., et al. (2018). Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients. Blood Advances, 2( 2), 126-141. doi:10.1182/bloodadvances.2017011072
NLM
Arruda LCM, Farias KCRM de, Lima Júnior JR, Clave E, Dias JBE, Moraes DA, Douay C, Fournier I, Moins-Teisserenc H, Alberdi AJ, Covas DT, Simões BP, Lansiaux P, Oliveira MC. Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients [Internet]. Blood Advances. 2018 ; 2( 2): 126-141.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1182/bloodadvances.2017011072
Vancouver
Arruda LCM, Farias KCRM de, Lima Júnior JR, Clave E, Dias JBE, Moraes DA, Douay C, Fournier I, Moins-Teisserenc H, Alberdi AJ, Covas DT, Simões BP, Lansiaux P, Oliveira MC. Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients [Internet]. Blood Advances. 2018 ; 2( 2): 126-141.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1182/bloodadvances.2017011072
Artigo de periodico
New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement (2018)
Couri, Carlos E. B.; Farias, Kelen Cristina Ribeiro Malmegrim de ; Oliveira, Maria Carolina
Fonte: Frontiers in Immunology. Unidades: FCFRP, FMRP
Assuntos: AUTOIMUNIDADE, CÉLULAS VEGETAIS, TRANSPLANTE DE ÓRGÃOS, BIOMARCADORES, DIABETES MELLITUS, TRANSPLANTE AUTÓLOGO, IMUNOSSUPRESSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COURI, Carlos E. B. e FARIAS, Kelen Cristina Ribeiro Malmegrim de e OLIVEIRA, Maria Carolina. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement. Frontiers in Immunology, v. 9, 2018Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2018.01086. Acesso em: 04 jul. 2024.
APA
Couri, C. E. B., Farias, K. C. R. M. de, & Oliveira, M. C. (2018). New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement. Frontiers in Immunology, 9. doi:10.3389/fimmu.2018.01086
NLM
Couri CEB, Farias KCRM de, Oliveira MC. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement [Internet]. Frontiers in Immunology. 2018 ; 9[citado 2024 jul. 04 ] Available from: https://doi.org/10.3389/fimmu.2018.01086
Vancouver
Couri CEB, Farias KCRM de, Oliveira MC. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement [Internet]. Frontiers in Immunology. 2018 ; 9[citado 2024 jul. 04 ] Available from: https://doi.org/10.3389/fimmu.2018.01086

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Assuntos

Título da fonte

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada